Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q2 2026 · 10-Q
Revenue$10.88M$10.88M+18.1% vs Q2 2025 Net Income-$11.34M-$11.34MN/M vs Q2 2025 EPS Diluted-$0.38-$0.38N/M vs Q2 2025 Gross Profit$6,710,000+20.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$7,015,000N/M Free Cash Flowderived-$7,229,000N/M Margins · derivedGross margin61.7%+1.4 pt vs Q2 2025
Operating margin-94.2%−32.5 pt vs Q2 2025
Net margin-104.2%−40.9 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 3, 2026 · 34 d after period end